Daniel Kracov

Daniel Kracov is a partner and chair of the firm's Global Life Sciences Industry group. He assists companies, trade associations and individuals in negotiating the broad range of regulatory and compliance challenges relating to the development, approval, manufacture, and marketing of drugs, biologics, medical devices and diagnostics. He handles complex investigations and enforcement matters, the development of corporate compliance programs, and due diligence in financings, mergers and acquisitions. He has a widely-recognized expertise in biomedical product-related public policy matters, including Congressional investigations.

JD, University of Virginia, 1988; BA, University of Maryland, 1985.